Showing results (1-10 of 1,005) with videos related to

Sort By:
Pageof 101
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 21, 2002
[Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy]Hiroaki Nagano, Masato Sakon, Morito Monden
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2003
[The chemotherapy for hepatocellular carcinoma]Hiroaki Nagano, Masato Sakon, Morito Monden
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2006
[FAIT (FU arterial infusion and interferon therapy) for hepatocellular carcinoma]Hiroaki Nagano, Morito Monden
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2003
[General surgery]Masato Sakon, Masataka Ikeda, Morito Monden
Archives of Surgery (Chicago, Ill. : 1960)|January 31, 2002
Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamicsMasato Sakon, Hiroaki Nagano, Shoji Nakamori, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 20, 2007
Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinomaBazarragchaa Damdinsuren, Hiroaki Nagano, Morito Monden
Surgery Today|March 2, 2002
Ischemia-reperfusion injury of the liver with special reference to calcium-dependent mechanismsMasato Sakon, Hideo Ariyoshi, Koji Umeshita, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 14, 2003
Association between expression levels of CA 19-9 and N-acetylglucosamine-beta;1,3-galactosyltransferase 5 gene in human pancreatic cancer tissueNobuyasu Hayashi, Shoji Nakamori, Jiro Okami, et al.
Anticancer Research|August 15, 2002
Linkage of elevated ets-2 expression to hepatocarcinogenesisYasuhiro Ito, Eiji Miyoshi, Tsutomu Takeda, et al.
Annals of Surgical Oncology|December 5, 2003
Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugsBazarragchaa Damdinsuren, Hiroaki Nagano, Masato Sakon, et al.
Pageof 101